Machine Perfusion of Donor Hearts – The Recovery and Transplantation of Previously Unrecoverable Hearts

Author:

Dutta Sanjay,Villanueva Jeanette E.,Joshi Yashutosh,Gao Ling,Jansz Paul,Macdonald Peter S.

Abstract

Heart transplantation remains the gold standard treatment for end-stage heart failure. With an increasing population and improving medical therapy there is an increasing number of patients who would benefit from heart transplantation but are unable to receive one due to a shortage of suitable donor organs. This ongoing need, and significant limitations with traditional cold static storage (CSS), have driven the development of machine perfusion technology that have expanded the donor pool. Machine perfusion is divided into hypothermic and normothermic, with both technologies perfusing the heart with oxygenated solution to reduce the degree of ischaemia-reperfusion injury that occurs. Both technologies have allowed for the safe retrieval and transplantation of hearts with prolonged ischaemic times or following donation after circulatory determination of death and have significantly increased the potential donor pool and number of transplants able to be safely performed. The aim of this review is to summarise the current options available to clinicians for donor heart organ preservation, with a focus on how the development of machine perfusion technology has allowed for the recovery of hearts previously considered unrecoverable using CSS.

Publisher

LIDSEN Publishing Inc

Reference70 articles.

1. Freudenberger RS, Kim J, Tawfik I, Sonnenberg FA. Optimal medical therapy is superior to transplantation for the treatment of class I, II, and III heart failure. Circulation. 2006; 114: I-62-I-66.

2. Barnard CN. The operation: A human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J. 1967; 41: 1271-1274.

3. Global Observatory on Donation and Transplantation. International report on organ donation and transplantation activities 2022. Global Observatory on Donation and Transplantation; 2023. Available from: https://www.transplant-observatory.org/wp-content/uploads/2016/02/2022-data-global-report_VF_2.pdf.

4. Organ and Tissue Authority. Australian Donation and Transplantation Activity Report 2022 [Internet]. Canberra, ACT, Australia: Organ and Tissue Authority; 2022. Available from: https://www.donatelife.gov.au/sites/default/files/2023-02/OTA%202022%20Donation%20and%20Transplantation%20Activity%20Report.pdf.

5. Australia & New Zealand Organ Donation Registry. Organ waiting list [Internet]. Adelaide, Australia: Australia & New Zealand Organ Donation Registry; 2022. Available from: https://www.anzdata.org.au/anzod/publications-2/organ-waiting-list/.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3